A Phase II, Multicenter, Open-Label, Single Arm Study to Evaluate the Safety, Tolerability, and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma

Sponsor
Cantex

Protocol Number
CAN-201

To Learn More Call
201-510-0910